Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1266042.RAwbpv9omFF73KJHnre9raUEhH3zB7rg0baSjhLU-e874130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1266042.RAwbpv9omFF73KJHnre9raUEhH3zB7rg0baSjhLU-e874130_assertion type Assertion NP1266042.RAwbpv9omFF73KJHnre9raUEhH3zB7rg0baSjhLU-e874130_head.
- NP1266042.RAwbpv9omFF73KJHnre9raUEhH3zB7rg0baSjhLU-e874130_assertion description "[Because CYP2D6 is known to be an important enzyme responsible for the generation of the potent tamoxifen metabolite, 'endoxifen', lots of studies reported that genetic variation which reduced its enzyme activity were associated with poor clinical outcome of breast cancer patients treated with tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266042.RAwbpv9omFF73KJHnre9raUEhH3zB7rg0baSjhLU-e874130_provenance.
- NP1266042.RAwbpv9omFF73KJHnre9raUEhH3zB7rg0baSjhLU-e874130_assertion evidence source_evidence_literature NP1266042.RAwbpv9omFF73KJHnre9raUEhH3zB7rg0baSjhLU-e874130_provenance.
- NP1266042.RAwbpv9omFF73KJHnre9raUEhH3zB7rg0baSjhLU-e874130_assertion SIO_000772 25712191 NP1266042.RAwbpv9omFF73KJHnre9raUEhH3zB7rg0baSjhLU-e874130_provenance.
- NP1266042.RAwbpv9omFF73KJHnre9raUEhH3zB7rg0baSjhLU-e874130_assertion wasDerivedFrom befree-2016 NP1266042.RAwbpv9omFF73KJHnre9raUEhH3zB7rg0baSjhLU-e874130_provenance.
- NP1266042.RAwbpv9omFF73KJHnre9raUEhH3zB7rg0baSjhLU-e874130_assertion wasGeneratedBy ECO_0000203 NP1266042.RAwbpv9omFF73KJHnre9raUEhH3zB7rg0baSjhLU-e874130_provenance.